Become a Partner in ASK
TO: Colorado Healthcare Providers
Please consider joining ASK to help assess the benefits and cost-effectiveness of universal screening for Childhood Diabetes (Type 1 Diabetes or T1D) and Celiac Disease (CD). T1D and CD are the most common autoimmune diseases of childhood, diagnosed in one in ~100 of Colorado children. Symptoms can be initially subtle and missed; however, serological markers are present for many months before overt symptoms.
In Colorado, over 40% of children diagnosed with T1D have life-threatening diabetic ketoacidosis (DKA). That rate can be cut to <10% when parents know that the child has islet autoantibodies, that is pre-T1D.
An estimated half of children with CD are undiagnosed and untreated. This could change with a universal screening for transglutaminase autoantibody. Early diagnosis and a gluten-free diet prevent poor growth, micro-nutrient deficiencies and long-term complications of CD.
As a provider, please join ASK to collect data that will determine whether preventive screening practices should include pre-T1D and CD. The ASK Research Program offers:
ASK staff will screen your patients, free of charge, working closely with your clinic staff in alignment with your practice needs.
Families may choose to be informed of the results by ASK via a letter or/and a phone call.
Treatment for Pre-T1D
Children with pre-T1D will be monitored by ASK at the Barbara Davis Center; their parents will receive free pre-diabetes management education.
These children will be eligible for intervention studies to start in late 2017.
Treatment for Celiac Disease
Children with undiagnosed CD will be referred back to you for follow up and/or to the Center for Celiac Disease at the Children’s Hospital Colorado.